We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DNA Toxicity Studies Should Weigh Sum of Test Results, EMA Says
DNA Toxicity Studies Should Weigh Sum of Test Results, EMA Says
January 10, 2012
Drugmakers testing drugs’ genotoxicity should consider the sum of the test results, as well as the intrinsic limitations of in vitro and in vivo tests, according to a revised European Medicines Agency (EMA) guideline.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor